US6875872B1
(en)
|
1993-05-28 |
2005-04-05 |
Astrazeneca |
Compounds
|
SE9301830D0
(sv)
*
|
1993-05-28 |
1993-05-28 |
Ab Astra |
New compounds
|
US5877192A
(en)
*
|
1993-05-28 |
1999-03-02 |
Astra Aktiebolag |
Method for the treatment of gastric acid-related diseases and production of medication using (-) enantiomer of omeprazole
|
ES2316333T3
(es)
|
1994-07-08 |
2009-04-16 |
Astrazeneca Ab |
Forma de dosificacion en tabletas constituida por unidades multiples.
|
SE504459C2
(sv)
*
|
1994-07-15 |
1997-02-17 |
Astra Ab |
Förfarande för framställning av substituerade sulfoxider
|
SE9500422D0
(sv)
*
|
1995-02-06 |
1995-02-06 |
Astra Ab |
New oral pharmaceutical dosage forms
|
SE9500478D0
(sv)
*
|
1995-02-09 |
1995-02-09 |
Astra Ab |
New pharmaceutical formulation and process
|
HRP960232A2
(en)
*
|
1995-07-03 |
1998-02-28 |
Astra Ab |
A process for the optical purification of compounds
|
US6699885B2
(en)
*
|
1996-01-04 |
2004-03-02 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and methods of using same
|
US5840737A
(en)
|
1996-01-04 |
1998-11-24 |
The Curators Of The University Of Missouri |
Omeprazole solution and method for using same
|
US6645988B2
(en)
|
1996-01-04 |
2003-11-11 |
Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
US6489346B1
(en)
*
|
1996-01-04 |
2002-12-03 |
The Curators Of The University Of Missouri |
Substituted benzimidazole dosage forms and method of using same
|
SE9600070D0
(sv)
|
1996-01-08 |
1996-01-08 |
Astra Ab |
New oral pharmaceutical dosage forms
|
SE508669C2
(sv)
*
|
1996-04-26 |
1998-10-26 |
Astra Ab |
Nytt förfarande
|
SE510666C2
(sv)
*
|
1996-12-20 |
1999-06-14 |
Astra Ab |
Nya Kristallmodifikationer
|
SE9702000D0
(sv)
*
|
1997-05-28 |
1997-05-28 |
Astra Ab |
New pharmaceutical formulation
|
US6747155B2
(en)
|
1997-05-30 |
2004-06-08 |
Astrazeneca Ab |
Process
|
SE510650C2
(sv)
|
1997-05-30 |
1999-06-14 |
Astra Ab |
Ny förening
|
SE510643C2
(sv)
*
|
1997-06-27 |
1999-06-14 |
Astra Ab |
Termodynamiskt stabil omeprazol natrium form B
|
US6174548B1
(en)
|
1998-08-28 |
2001-01-16 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
US6096340A
(en)
*
|
1997-11-14 |
2000-08-01 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
HUP0100043A2
(hu)
*
|
1997-12-08 |
2001-08-28 |
Byk Gulden Lomberg Chemische Fabrik Gmbh. |
Savérzékeny hatóanyagot tartalmazó új gyógyszerforma
|
SE9704870D0
(sv)
*
|
1997-12-22 |
1997-12-22 |
Astra Ab |
New pharmaceutical formulation I
|
SE9704869D0
(sv)
*
|
1997-12-22 |
1997-12-22 |
Astra Ab |
New pharmaceutical formulaton II
|
KR100627614B1
(ko)
*
|
1998-04-20 |
2006-09-25 |
에자이 가부시키가이샤 |
안정화된 벤즈이미다졸계 화합물 함유 조성물로 이루어지는 의약제제
|
CN100396675C
(zh)
|
1998-08-10 |
2008-06-25 |
加利福尼亚州大学董事会 |
质子泵抑制剂的前药
|
US6733778B1
(en)
*
|
1999-08-27 |
2004-05-11 |
Andrx Pharmaceuticals, Inc. |
Omeprazole formulation
|
SE9803772D0
(sv)
|
1998-11-05 |
1998-11-05 |
Astra Ab |
Pharmaceutical formulation
|
EP1131316B1
(de)
|
1998-11-18 |
2004-07-21 |
AstraZeneca AB |
Verbesserter chemischer prozess und eine pharmazeutische zubereitung
|
SE9900274D0
(sv)
*
|
1999-01-28 |
1999-01-28 |
Astra Ab |
New compound
|
US6852739B1
(en)
*
|
1999-02-26 |
2005-02-08 |
Nitromed Inc. |
Methods using proton pump inhibitors and nitric oxide donors
|
TWI243672B
(en)
|
1999-06-01 |
2005-11-21 |
Astrazeneca Ab |
New use of compounds as antibacterial agents
|
WO2000076556A2
(en)
*
|
1999-06-11 |
2000-12-21 |
Neorx Corporation |
High dose radionuclide complexes for bone marrow suppression
|
US7094885B2
(en)
*
|
1999-07-11 |
2006-08-22 |
Neorx Corporation |
Skeletal-targeted radiation to treat bone-associated pathologies
|
EP1595879A3
(de)
*
|
1999-08-26 |
2010-01-27 |
aaiPharma Inc. |
Alkoxy substituierte Benzimidazolverbindungen , diese enthaltende Arzneimittel und ihre Vervendung
|
US6369087B1
(en)
|
1999-08-26 |
2002-04-09 |
Robert R. Whittle |
Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
US6262085B1
(en)
*
|
1999-08-26 |
2001-07-17 |
Robert R. Whittle |
Alkoxy substituted Benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same
|
US6316020B1
(en)
|
1999-08-26 |
2001-11-13 |
Robert R. Whittle |
Pharmaceutical formulations
|
US6326384B1
(en)
|
1999-08-26 |
2001-12-04 |
Robert R. Whittle |
Dry blend pharmaceutical unit dosage form
|
US6312712B1
(en)
|
1999-08-26 |
2001-11-06 |
Robert R. Whittle |
Method of improving bioavailability
|
US6312723B1
(en)
|
1999-08-26 |
2001-11-06 |
Robert R. Whittle |
Pharmaceutical unit dosage form
|
US6780880B1
(en)
|
1999-08-26 |
2004-08-24 |
Robert R. Whittle |
FT-Raman spectroscopic measurement
|
US6268385B1
(en)
|
1999-08-26 |
2001-07-31 |
Robert R. Whittle |
Dry blend pharmaceutical formulations
|
US6262086B1
(en)
|
1999-08-26 |
2001-07-17 |
Robert R. Whittle |
Pharmaceutical unit dosage form
|
JP2003510348A
(ja)
*
|
1999-10-01 |
2003-03-18 |
ナトコ ファーマ リミテッド |
改良された薬学的組成物およびその製造方法
|
JP4081273B2
(ja)
*
|
1999-10-20 |
2008-04-23 |
エーザイ・アール・アンド・ディー・マネジメント株式会社 |
ベンズイミダゾール系化合物安定化方法
|
SE9903831D0
(sv)
|
1999-10-22 |
1999-10-22 |
Astra Ab |
Formulation of substituted benzimidazoles
|
AU5424500A
(en)
|
2000-02-24 |
2001-09-03 |
Kopran Res Lab Ltd |
Orally administrable acid stable anti-ulcer benzimidazole derivatives
|
SE0000774D0
(sv)
|
2000-03-08 |
2000-03-08 |
Astrazeneca Ab |
New formulation
|
AU5248601A
(en)
*
|
2000-05-15 |
2001-11-26 |
Ranbaxy Laboratories Limited |
Novel amorphous form of omeprazole salts
|
US6306435B1
(en)
*
|
2000-06-26 |
2001-10-23 |
Yung Shin Pharmaceutical Industrial Co. Ltd. |
Oral pharmaceutical preparation embedded in an oily matrix and methods of making the same
|
AU2003204233B8
(en)
*
|
2000-08-04 |
2008-06-26 |
Bernard Charles Sherman |
Magnesium salt of S-omeprazole
|
CA2386716C
(en)
*
|
2002-05-17 |
2012-07-24 |
Bernard Charles Sherman |
Magnesium salt of s-omeprazole
|
ATE342263T1
(de)
|
2000-08-04 |
2006-11-15 |
Takeda Pharmaceutical |
Salze von benzimidazol-derivaten und deren verwendung
|
US6544556B1
(en)
|
2000-09-11 |
2003-04-08 |
Andrx Corporation |
Pharmaceutical formulations containing a non-steroidal antiinflammatory drug and a proton pump inhibitor
|
US20020064555A1
(en)
*
|
2000-09-29 |
2002-05-30 |
Dan Cullen |
Proton pump inhibitor formulation
|
EP1390081A2
(de)
|
2001-01-08 |
2004-02-25 |
Neorx Corporation |
Therapeutische und diagnostische verbindungen, zusammenstellungen und methoden
|
AU2002338655A1
(en)
*
|
2001-04-13 |
2002-10-28 |
Aspinterm Llc |
Methods of preparing sulfinamide and sulfoxides
|
SE0101379D0
(sv)
|
2001-04-18 |
2001-04-18 |
Diabact Ab |
Komposition som hämmar utsöndring av magsyra
|
US8206741B2
(en)
|
2001-06-01 |
2012-06-26 |
Pozen Inc. |
Pharmaceutical compositions for the coordinated delivery of NSAIDs
|
GB2376231A
(en)
*
|
2001-06-06 |
2002-12-11 |
Cipla Ltd |
Benzimidazole-cyclodextrin inclusion complex
|
SE0102993D0
(sv)
|
2001-09-07 |
2001-09-07 |
Astrazeneca Ab |
New self emulsifying drug delivery system
|
CA2445513A1
(en)
|
2001-09-18 |
2003-03-27 |
Zeria Pharmaceutical Co., Ltd. |
Benzimidazole derivatives
|
JP2005521662A
(ja)
*
|
2002-01-25 |
2005-07-21 |
サンタラス インコーポレイティッド |
プロトンポンプ阻害剤の経粘膜送達
|
AU2003208686A1
(en)
|
2002-03-05 |
2003-09-16 |
Astrazeneca Ab |
Alkylammonium salts of omeprazole and esomeprazole
|
KR101061351B1
(ko)
|
2002-04-09 |
2011-08-31 |
플라멜 테크놀로지스 |
활성 성분 마이크로캡슐의 경구 현탁액
|
US6894066B2
(en)
*
|
2002-05-09 |
2005-05-17 |
Bernard Charles Sherman |
Magnesium salt of S-omeprazole
|
EP1556371B1
(de)
*
|
2002-07-19 |
2006-04-19 |
Winston Pharmaceuticals LLC |
Benzimidazolderivative und ihre verwendung als prodrugs für protonenpumpenhemmer
|
TW200410955A
(en)
*
|
2002-07-29 |
2004-07-01 |
Altana Pharma Ag |
Novel salt of (S)-PANTOPRAZOLE
|
US7211590B2
(en)
*
|
2002-08-01 |
2007-05-01 |
Nitromed, Inc. |
Nitrosated proton pump inhibitors, compositions and methods of use
|
EP1546131A1
(de)
|
2002-08-30 |
2005-06-29 |
Dr. Reddy's Laboratories Ltd. |
Amorphe hydrate von esomeprazol-magnesium und verfahren zu deren herstellung
|
EP2596792A1
(de)
|
2002-10-16 |
2013-05-29 |
Takeda Pharmaceutical Company Limited |
Stabile, feste Präparate
|
SE0203065D0
(sv)
|
2002-10-16 |
2002-10-16 |
Diabact Ab |
Gastric acid secretion inhibiting composition
|
US20040235903A1
(en)
*
|
2002-10-22 |
2004-11-25 |
Khanna Mahavir Singh |
Amorphous form of esomeprazole salts
|
US20040242642A1
(en)
*
|
2002-11-18 |
2004-12-02 |
Dr. Reddy's Laboratories Limited |
Crystalline esomeprazole compounds and process for the preparation thereof
|
DE10254167A1
(de)
|
2002-11-20 |
2004-06-09 |
Icon Genetics Ag |
Verfahren zur Kontrolle von zellulären Prozessen in Pflanzen
|
EP1575941B1
(de)
|
2002-12-06 |
2012-04-11 |
Nycomed GmbH |
Verfahren zur Herstellung von (S)-Pantoprazol
|
AR042277A1
(es)
|
2002-12-06 |
2005-06-15 |
Altana Pharma Ag |
Un procedimiento para la preparacion de sulfinil benzimidazoles opticamente puros
|
FR2848555B1
(fr)
|
2002-12-16 |
2006-07-28 |
Negma Gild |
Enantiomere(-)du tenatoprazole et son application en therapeutique
|
US20040166162A1
(en)
*
|
2003-01-24 |
2004-08-26 |
Robert Niecestro |
Novel pharmaceutical formulation containing a proton pump inhibitor and an antacid
|
JP2006518751A
(ja)
*
|
2003-02-20 |
2006-08-17 |
サンタラス インコーポレイティッド |
胃酸の急速かつ持続的な抑制のための新規製剤、オメプラゾール制酸剤複合体−即時放出物
|
CN1777598A
(zh)
*
|
2003-02-28 |
2006-05-24 |
兰贝克赛实验室有限公司 |
S-奥美拉唑的多晶型物
|
AU2003238671A1
(en)
*
|
2003-04-10 |
2004-11-01 |
Hetero Drugs Limitd |
Novel crystalline forms of s-omeprazole magnesium
|
US20070060556A1
(en)
*
|
2003-05-05 |
2007-03-15 |
Yatendra Kumar |
Barium salt of benzimidazole derivative
|
WO2004099182A1
(en)
*
|
2003-05-05 |
2004-11-18 |
Ranbaxy Laboratories Limited |
Zinc salt of (s)-omeprazole
|
KR20060041224A
(ko)
*
|
2003-07-15 |
2006-05-11 |
알러간, 인코포레이티드 |
양성자 펌프 억제제의 이성질체적으로 순수한 프로드러그를제조하는 방법
|
MXPA06000529A
(es)
*
|
2003-07-18 |
2006-08-11 |
Santarus Inc |
Formulaciones farmaceuticas utiles para inhibir la secrecion de acido y metodos para elaborarlas y utilizarlas.
|
EP1648417A4
(de)
*
|
2003-07-18 |
2010-01-20 |
Santarus Inc |
Pharmazeutische formulierung und verfahren zur behandlung von säurebedingten gastrointestinalen erkrankungen
|
US8993599B2
(en)
|
2003-07-18 |
2015-03-31 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
CA2532774A1
(en)
*
|
2003-07-23 |
2005-02-10 |
Altana Pharma Ag |
Alkaline salts of proton pump inhibitors
|
CN100457104C
(zh)
*
|
2003-07-23 |
2009-02-04 |
尼科梅德有限责任公司 |
质子泵抑制剂的碱性盐
|
US20060165793A1
(en)
*
|
2003-08-04 |
2006-07-27 |
Koji Ukai |
Pharmaceutical preparation to be dispersed before administration
|
SE0302382D0
(sv)
|
2003-09-04 |
2003-09-04 |
Astrazeneca Ab |
New salts II
|
SE0302381D0
(sv)
|
2003-09-04 |
2003-09-04 |
Astrazeneca Ab |
New salts I
|
CA2540105A1
(en)
*
|
2003-09-25 |
2005-03-31 |
Natco Pharma Limited |
Enteric soft gelatin capsule containing esomeprazole and method of preparation
|
ATE544447T1
(de)
|
2003-09-26 |
2012-02-15 |
Alza Corp |
Arzneistoffcoating mit hohem wirkstoffanteil sowie methoden zu dessen herstellung
|
US20050075371A1
(en)
*
|
2003-10-03 |
2005-04-07 |
Allergan, Inc. |
Methods and compositions for the oral administration of prodrugs of proton pump inhibitors
|
AU2003272086A1
(en)
*
|
2003-10-14 |
2005-04-27 |
Natco Pharma Limited |
Enteric coated pellets comprising esomeprazole, hard gelatin capsule containing them, and method of preparation
|
GB0403165D0
(en)
*
|
2004-02-12 |
2004-03-17 |
Ct |
Novel uses for proton pump inhibitors
|
WO2005082338A2
(en)
*
|
2004-02-18 |
2005-09-09 |
Allergan, Inc. |
Prodrugs for the intravenous administration of proton pump inhibitors
|
BRPI0507784A
(pt)
*
|
2004-02-18 |
2007-07-17 |
Allergan Inc |
métodos e composições para a administração de pró-fármacos de inibidores da bomba de prótons
|
SE0400410D0
(sv)
|
2004-02-20 |
2004-02-20 |
Astrazeneca Ab |
New compounds
|
WO2005082888A1
(en)
*
|
2004-03-01 |
2005-09-09 |
Milen Merkez Ilac Endustrisi A.S. |
Process for the preparation of magnesium salt of omeprazole
|
PT1740571E
(pt)
|
2004-04-28 |
2009-09-02 |
Hetero Drugs Ltd |
Processo para preparar compostos de piridinilmetil-1hbenzimidazol na forma enantiomericamente enriquecida ou como enantiómeros únicos
|
US8815916B2
(en)
|
2004-05-25 |
2014-08-26 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US8906940B2
(en)
|
2004-05-25 |
2014-12-09 |
Santarus, Inc. |
Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them
|
US7365206B2
(en)
*
|
2004-05-28 |
2008-04-29 |
Hetero Drugs Limited |
Stereoselective synthesis of benzimidazole sulfoxides
|
US20050267157A1
(en)
*
|
2004-05-28 |
2005-12-01 |
David White |
Magnesium-S-omeprazole
|
US20050267159A1
(en)
*
|
2004-05-28 |
2005-12-01 |
Aaipharma, Inc. |
Magnesium complexes of S-omeprazole
|
AU2005257709C1
(en)
*
|
2004-06-24 |
2011-02-24 |
Astrazeneca Ab |
New process for the preparation of crystal modifications for use in the preparation of esomeprazole sodium salt
|
WO2006001755A1
(en)
*
|
2004-06-24 |
2006-01-05 |
Astrazeneca Ab |
A new esomeprazole sodium salt crystal modification
|
US20060024362A1
(en)
*
|
2004-07-29 |
2006-02-02 |
Pawan Seth |
Composition comprising a benzimidazole and process for its manufacture
|
EP1775292B1
(de)
|
2004-08-06 |
2012-06-27 |
Eisai R&D Management Co., Ltd. |
Salze von benzimidazolderivaten mit aminen und verfahren zu deren herstellung
|
KR100847635B1
(ko)
*
|
2004-08-06 |
2008-07-21 |
에자이 알앤드디 매니지먼트 가부시키가이샤 |
벤즈이미다졸 유도체와 아민과의 염
|
US8541026B2
(en)
|
2004-09-24 |
2013-09-24 |
Abbvie Inc. |
Sustained release formulations of opioid and nonopioid analgesics
|
WO2006066932A1
(en)
*
|
2004-12-24 |
2006-06-29 |
Lek Pharmaceuticals D.D. |
Stable pharmaceutical composition comprising an active substance in the form of solid solution
|
US20060160783A1
(en)
*
|
2004-12-30 |
2006-07-20 |
Transform Pharmaceuticals, Inc. |
Novel omeprazole forms and related methods
|
ES2259269B1
(es)
|
2005-03-03 |
2007-11-01 |
Esteve Quimica, S.A. |
Procedimiento para la preparacion de derivados de 2-(2-piridilmetilsulfinil)-bencimidazol opticamente activos.
|
ATE528301T1
(de)
|
2005-03-25 |
2011-10-15 |
Livzon Pharmaceutical Group |
Verfahren zur herstellung von substituierten sulfoxidzusammensetzungen
|
RU2007145207A
(ru)
*
|
2005-05-06 |
2009-06-20 |
Гленмарк Фармасьютикалз Лимитед (In) |
Стронциваемая соль эзомепразола, способ ее получения и содержащее ее фармацевтические композиции
|
US8841333B2
(en)
*
|
2005-05-09 |
2014-09-23 |
Takeda Pharmaceuticals U.S.A., Inc. |
Methods for treating nephrolithiasis
|
US7981908B2
(en)
|
2005-05-11 |
2011-07-19 |
Vecta, Ltd. |
Compositions and methods for inhibiting gastric acid secretion
|
US7803817B2
(en)
|
2005-05-11 |
2010-09-28 |
Vecta, Ltd. |
Composition and methods for inhibiting gastric acid secretion
|
WO2006134605A1
(en)
|
2005-06-15 |
2006-12-21 |
Hetero Drugs Limited |
Amorphous esomeprazole hydrate
|
KR100641534B1
(ko)
*
|
2005-07-28 |
2006-11-01 |
한미약품 주식회사 |
에스오메프라졸 및 그의 염의 제조방법
|
US20070167454A1
(en)
*
|
2005-08-03 |
2007-07-19 |
Christopher Lademacher |
Methods for treating hypertension
|
US20070043085A1
(en)
*
|
2005-08-19 |
2007-02-22 |
Glenmark Pharmaceuticals Limited |
Process for the preparation of amorphous form of neutral esomeprazole
|
WO2007031845A2
(en)
*
|
2005-09-14 |
2007-03-22 |
Glenmark Pharmaceuticals Limited |
Polymorphic forms of (s)-omeprazole magnesium salts and processes for their preparation
|
CA2624179A1
(en)
*
|
2005-10-06 |
2007-04-12 |
Auspex Pharmaceuticals, Inc. |
Deuterated inhibitors of gastric h+, k+-atpase with enhanced therapeutic properties
|
US7576219B2
(en)
|
2005-10-26 |
2009-08-18 |
Hanmi Pharm. Co., Ltd |
Crystalline S-omeprazole strontium hydrate, method for preparing same, and pharmaceutical composition containing same
|
BRPI0619158A2
(pt)
|
2005-12-05 |
2011-09-20 |
Astrazeneca Ab |
processo para preparar forma que não que não seja sal de esomeprazol, composto, formulação farmacêutica, e, método de tratamento
|
EP1801110A1
(de)
|
2005-12-22 |
2007-06-27 |
KRKA, tovarna zdravil, d.d., Novo mesto |
Argininsalz des Esomeprazols
|
US7553857B2
(en)
|
2005-12-23 |
2009-06-30 |
Lek Pharmaceuticals D.D. |
S-omeprazole magnesium
|
CA2631459A1
(en)
*
|
2005-12-28 |
2007-07-05 |
Union Quimico Farmaceutica, S.A. |
A process for the preparation of the (s)-enantiomer of omeprazole
|
US8063074B2
(en)
*
|
2006-05-04 |
2011-11-22 |
Dr. Reddy's Laboratories Limited |
Polymorphic forms of esomeprazole sodium
|
ES2355164T3
(es)
*
|
2006-06-07 |
2011-03-23 |
Astrazeneca Ab |
Nuevo método para la preparación de sales de amonio de esomeprazol.
|
US7863330B2
(en)
*
|
2006-06-14 |
2011-01-04 |
Rottapharm S.P.A. |
Deloxiglumide and proton pump inhibitor combination in the treatment of gastrointestinal disorders
|
AU2006345861B2
(en)
|
2006-07-05 |
2012-07-12 |
Lupin Limited |
Process for the preparation of optically pure or optically enriched enantiomers of sulphoxide compounds
|
PL2046334T3
(pl)
|
2006-07-25 |
2015-02-27 |
Vecta Ltd |
Kompozycje i sposoby hamowania wydzielania kwasów żołądkowych z wykorzystaniem pochodnych małych kwasów dikarboksylowych w połączeniu z PPI
|
US20100317689A1
(en)
*
|
2006-09-19 |
2010-12-16 |
Garst Michael E |
Prodrugs of proton pump inhibitors including the 1h-imidazo[4,5-b] pyridine moiety
|
GB2444593B
(en)
|
2006-10-05 |
2010-06-09 |
Santarus Inc |
Novel formulations for immediate release of proton pump inhibitors and methods of using these formulations
|
US20090092658A1
(en)
*
|
2007-10-05 |
2009-04-09 |
Santarus, Inc. |
Novel formulations of proton pump inhibitors and methods of using these formulations
|
MX2009004475A
(es)
|
2006-10-27 |
2009-08-12 |
Univ Missouri |
Composiciones que comprenden agentes acido labiles que inhiben la bomba de protones, por lo menos otro agente farmaceuticamente activo y metodos de uso de las misma.
|
US20090124623A1
(en)
*
|
2006-11-13 |
2009-05-14 |
Christopher Lademacher |
Methods for preserving and/or increasing renal function using xanthine oxidoreductase inhibitors
|
MX2009004984A
(es)
*
|
2006-11-13 |
2009-09-23 |
Takeda Pharmaceuticals North A |
Metodos para conservar la funcion renal utilizando inhibidores de oxidoreductasa de xantina.
|
EP1947099A1
(de)
|
2007-01-18 |
2008-07-23 |
LEK Pharmaceuticals D.D. |
Verfahren zur Entfernung von Lösungsmitteln in Omeprazol-Salzen
|
MX2009007680A
(es)
*
|
2007-01-19 |
2011-08-03 |
Takeda Pharmaceuticals North America Inc |
Metodos para prevenir o reducir el numero de expansiones graduales de gota utilizando inhibidores de oxidoreductasa de xantina y agentes anti-inflamatorios.
|
EA200900985A1
(ru)
*
|
2007-01-31 |
2009-12-30 |
Крка, Товарна Здравил, Д. Д., Ново Место |
Способ получения оптически чистого омепразола
|
US20080194307A1
(en)
*
|
2007-02-13 |
2008-08-14 |
Jeff Sanger |
Sports-based game of chance
|
WO2008102145A2
(en)
|
2007-02-21 |
2008-08-28 |
Cipla Limited |
Process for the preparation of esomeprazole magnesium dihydrate
|
KR101303813B1
(ko)
*
|
2007-04-16 |
2013-09-04 |
에스케이케미칼주식회사 |
라세믹 오메프라졸로부터 에스오메프라졸의 개선된제조방법
|
EP2000468A1
(de)
*
|
2007-05-09 |
2008-12-10 |
Dr. Reddy's Laboratories Ltd. |
Esomeprazolsalze und Verfahren zur Herstellung davon
|
EP2152691B1
(de)
*
|
2007-06-07 |
2011-11-23 |
Aurobindo Pharma Limited |
Verbessertes verfahren zur herstellung eines optisch aktiven protonenpumpenhemmers
|
CN101323609B
(zh)
*
|
2007-06-15 |
2013-05-01 |
成都福瑞生物工程有限公司 |
不对称氧化硫醚成亚砜合成对映体含量高的苯并咪唑衍生物的方法
|
DK2106397T3
(da)
|
2007-09-25 |
2012-01-30 |
Hetero Drugs Ltd |
Fremgangsmåde til fremstilling af enantiomer-ren esomeprazol
|
WO2009047775A2
(en)
*
|
2007-10-08 |
2009-04-16 |
Hetero Drugs Limited |
Polymorphs of esomeprazole salts
|
FR2925899B1
(fr)
*
|
2007-12-27 |
2012-12-21 |
Sidem Pharma Sa |
Procede de preparation enantioselective de sulfoxydes.
|
CA2716367C
(en)
|
2008-02-20 |
2015-05-26 |
The Curators Of The University Of Missouri |
Composition comprising a combination of omeprazole and lansoprazole, and a buffering agent, and methods of using same
|
US20090280175A1
(en)
*
|
2008-05-09 |
2009-11-12 |
Ishwar Chauhan |
Multilayer Proton Pump Inhibitor Tablets
|
US20090280173A1
(en)
*
|
2008-05-09 |
2009-11-12 |
Ishwar Chauhan |
Multilayer Omeprazole Tablets
|
WO2009145368A1
(en)
*
|
2008-05-27 |
2009-12-03 |
Sk Chemicals Co., Ltd. |
Improved preparing method of (s)-omeprazole from omeprazole racemate using optical resolution agent
|
EP2143722A1
(de)
*
|
2008-07-09 |
2010-01-13 |
Lek Pharmaceuticals D.D. |
Verfahren zur Herstellung von Esomeprazol-Natrium von hoher chemischer Reinheit und neue Formen von Esomeprazol-Natrium
|
EP2147918A1
(de)
|
2008-07-21 |
2010-01-27 |
LEK Pharmaceuticals D.D. |
Verfahren zur Herstellung von S-Omeprazol-Magnesium in einer stabilen Form
|
US9220698B2
(en)
|
2008-09-09 |
2015-12-29 |
Pozen Inc. |
Method for delivering a pharmaceutical composition to patient in need thereof
|
EP2264024A1
(de)
|
2008-10-14 |
2010-12-22 |
LEK Pharmaceuticals d.d. |
Verfahren zur Herstellung einer enantiomerisch-angereicherte Protonpumpenhemmer
|
WO2010058409A2
(en)
|
2008-11-18 |
2010-05-27 |
Hetero Research Foundation |
Optical purification of esomeprazole
|
US20100311756A1
(en)
*
|
2009-01-22 |
2010-12-09 |
Takeda Pharmaceuticals North America, Inc. |
Methods for delaying the progression of at least one of cardiac hypertrophy, cardiac remodeling or left ventricular function or the onset of heart failure in subjects in need of treatment thereof
|
WO2010097583A1
(en)
|
2009-02-24 |
2010-09-02 |
Cipla Limited |
Esomeprazole potassium polymorph and its preparation
|
EP2445344A4
(de)
*
|
2009-06-25 |
2013-01-23 |
Pozen Inc |
Verfahren zur behandlung eines patienten mit bedarf an einer aspirintherapie
|
EA201290026A1
(ru)
|
2009-06-25 |
2012-07-30 |
Астразенека Аб |
Способ лечения пациента, имеющего риск развития язвы, связанной с приемом нестероидных противовоспалительных средств (nsaid)
|
EP2319504A1
(de)
|
2009-11-07 |
2011-05-11 |
Laboratorios Del. Dr. Esteve, S.A. |
Feste pharmazeutische Dosierform
|
WO2011058569A1
(en)
|
2009-11-12 |
2011-05-19 |
Hetero Research Foundation |
Process for the resolution of omeprazole
|
EP2519229A2
(de)
|
2009-12-29 |
2012-11-07 |
Novartis AG |
Neue pharmazeutische darreichungsform zur behandlung von magensäurebedingten erkrankungen
|
WO2011080502A2
(en)
|
2009-12-29 |
2011-07-07 |
Orexo Ab |
New pharmaceutical dosage form for the treatment of gastric acid-related disorders
|
WO2011080500A2
(en)
|
2009-12-29 |
2011-07-07 |
Orexo Ab |
New pharmaceutical dosage form for the treatment of gastric acid-related disorders
|
EP2345408A3
(de)
|
2010-01-08 |
2012-02-29 |
Dr. Reddy's Laboratories Ltd. |
Säurelabile Arzneimittelformulierungen
|
MX2012009220A
(es)
|
2010-02-12 |
2012-09-07 |
Esteve Quimica Sa |
Procedimiento de preparacion de la sal sodica de esomeprazol.
|
US20110207779A1
(en)
*
|
2010-02-25 |
2011-08-25 |
Glenmark Generics Ltd |
Process for the preparation of esomeprazole magnesium
|
AU2011299153B2
(en)
|
2010-09-10 |
2014-10-30 |
Takeda Pharmaceuticals U.S.A., Inc. |
Methods for concomitant treatment of theophylline and febuxostat
|
CN102816149B
(zh)
*
|
2011-06-10 |
2015-05-13 |
上海汇伦生命科技有限公司 |
一种高对映选择性合成(s)-奥美拉唑及其盐的制备方法
|
CN102807561A
(zh)
*
|
2011-06-21 |
2012-12-05 |
寿光富康制药有限公司 |
S-奥美拉唑铝盐及其制备方法和应用
|
CN102850323A
(zh)
*
|
2011-06-30 |
2013-01-02 |
秦引林 |
一种埃索美拉唑钠的精制方法
|
CN102321071B
(zh)
*
|
2011-07-20 |
2013-01-23 |
江苏奥赛康药业股份有限公司 |
一种高纯度埃索美拉唑钠的工业化生产方法
|
CN104844577A
(zh)
*
|
2011-07-31 |
2015-08-19 |
连云港润众制药有限公司 |
埃索美拉唑镁的晶型
|
WO2013081566A1
(en)
|
2011-11-25 |
2013-06-06 |
Mahmut Bilgic |
A formulation comprising benzimidazole
|
EP2601947A1
(de)
|
2011-12-05 |
2013-06-12 |
Abo Bakr Mohammed Ali Al-Mehdar |
Kombinationspräparat mit fester Dosierung zur Behandlung von Erkrankungen einhergehend mit Helicobacter pylori
|
BR112014014558A8
(pt)
|
2011-12-16 |
2017-07-04 |
Atopix Therapeutics Ltd |
composição farmacêutica, uso de um antagonista de crth2 e de um inibidor de bomba de prótons, e, kit para o tratamento de esofagite eosinofílica
|
UA115139C2
(uk)
|
2011-12-28 |
2017-09-25 |
Поузен Інк. |
Спосіб доставки фармацевтичної композиції, яка містить омепразол й ацетилсаліцилову кислоту, пацієнту
|
CN104203938A
(zh)
|
2012-01-21 |
2014-12-10 |
朱比兰特生命科学有限公司 |
用于制备2-吡啶基甲基亚硫酰基苯并咪唑、它们的类似物和光学活性对映体的方法
|
CN103420978A
(zh)
*
|
2012-05-15 |
2013-12-04 |
上海医药工业研究院 |
一种苯并咪唑类化合物的镁盐的制备方法
|
CN102657622A
(zh)
*
|
2012-05-17 |
2012-09-12 |
康普药业股份有限公司 |
一种含有埃索美拉唑钠的冻干粉针剂的制备工艺
|
CN102964335B
(zh)
*
|
2012-11-13 |
2014-06-25 |
凌元敏 |
一种埃索美拉唑钠化合物及其制备方法和用途
|
CN103159737B
(zh)
*
|
2013-04-12 |
2014-03-19 |
四川省惠达药业有限公司 |
一种埃索美拉唑钠化合物及药物组合物
|
US20160256399A1
(en)
|
2013-11-04 |
2016-09-08 |
Capsugel Belgium Nv |
Methods and systems for improved bioavailability of active pharmaceutical ingredients including esomeprazole
|
EP2933002A1
(de)
|
2014-04-11 |
2015-10-21 |
Sanovel Ilac Sanayi ve Ticaret A.S. |
Pharmazeutische kombinationen von dabigatran und protonenpumpeninhibitoren
|
EP2929885A1
(de)
|
2014-04-11 |
2015-10-14 |
Sanovel Ilac Sanayi ve Ticaret A.S. |
Pharmazeutische kombinationen von rivaroxaban und protonenpumpenhemmern
|
CN104045627A
(zh)
*
|
2014-05-21 |
2014-09-17 |
丽珠医药集团股份有限公司 |
一种奥美拉唑纯化方法
|
CN104530003A
(zh)
*
|
2014-06-10 |
2015-04-22 |
广东东阳光药业有限公司 |
吡啶甲基亚磺酰基-1h-苯并咪唑类化合物的盐的制备方法
|
EP2980086B1
(de)
|
2014-07-29 |
2016-06-15 |
F.I.S.- Fabbrica Italiana Sintetici S.p.A. |
Effizientes Verfahren zur Herstellung von Esomeprazol (S)-Binol Komplex
|
JP6548336B2
(ja)
|
2014-12-26 |
2019-07-24 |
国立大学法人 東京大学 |
光学活性のプロトンポンプ阻害化合物の製造方法
|
EP3064495B1
(de)
|
2015-03-06 |
2016-12-14 |
F.I.S.- Fabbrica Italiana Sintetici S.p.A. |
Verbessertes verfahren zur herstellung von optisch reinen esomeprazole
|
US10736855B2
(en)
|
2016-02-25 |
2020-08-11 |
Dexcel Pharma Technologies Ltd. |
Compositions comprising proton pump inhibitors
|
CN105924430A
(zh)
*
|
2016-06-27 |
2016-09-07 |
杭州富阳伟文环保科技有限公司 |
一种埃索美拉唑钠的精制方法
|
US10939686B2
(en)
*
|
2017-04-11 |
2021-03-09 |
Mclaughlin Gormley King Company |
Sabadilla oil and uses thereof
|
CN108409714A
(zh)
*
|
2018-03-29 |
2018-08-17 |
成都通德药业有限公司 |
埃索美拉唑、埃索美拉唑盐及埃索美拉唑镁的制备方法
|
WO2021011645A1
(en)
*
|
2019-07-16 |
2021-01-21 |
Kindred Biosciences, Inc. |
Equine esomeprazole formulations and methods of use
|
US20220306593A1
(en)
|
2019-08-29 |
2022-09-29 |
Tokyo University Of Science Foundation |
Method for preparing enantiomer of sulfoxide compound, and system for preparing enantiomer
|
RU2726320C1
(ru)
*
|
2020-02-09 |
2020-07-13 |
Федеральное государственное бюджетное образовательное учреждение высшего образования "Кемеровский государственный медицинский университет" Министерства здравоохранения Российской Федерации (ФГБОУ ВО КемГМУ) |
Способ определения примесных компонентов омепразола
|
WO2024075017A1
(en)
|
2022-10-04 |
2024-04-11 |
Zabirnyk Arsenii |
Inhibition of aortic valve calcification
|